U.S. Markets closed

GlaxoSmithKline plc (GSK)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
44.29+0.13 (+0.29%)
At close: 4:02PM EDT
People also watch
AZNNVSSNYLLYBMY
Full screen
Previous Close44.16
Open44.23
Bid0.00 x
Ask0.00 x
Day's Range44.10 - 44.38
52 Week Range37.20 - 45.58
Volume1,981,144
Avg. Volume3,001,470
Market Cap107.6B
Beta1.06
PE Ratio (TTM)51.26
EPS (TTM)0.86
Earnings DateFeb 1, 2017 - Feb 6, 2017
Dividend & Yield1.95 (4.48%)
Ex-Dividend Date2017-05-10
1y Target Est47.55
Trade prices are not sourced from all markets
  • GSK's new CEO aims to divest sports nutrition brand: sources
    Reuters2 days ago

    GSK's new CEO aims to divest sports nutrition brand: sources

    GlaxoSmithKline Plc's new Chief Executive Officer Emma Walmsley is shaking up the British drugmaker's portfolio of smaller products with plans to divest its MaxiNutrition sports nutrition brand, two people familiar with the matter said on Thursday. GSK bought the business, which makes protein bars, drinks and powders, for 162 million pounds ($205 million) in 2010 under previous CEO Andrew Witty. The original acquisition was seen as complementing GSK's Lucozade sports drinks.

  • Glaxo's (GSK) Shingles Candidate Phase III Data Positive
    Zacks2 days ago

    Glaxo's (GSK) Shingles Candidate Phase III Data Positive

    GlaxoSmithKline plc (GSK) announced positive top-line results from a phase III revaccination study on its shingles vaccine candidate, Shingrix, in older patients.

  • CNBC2 days ago

    Early movers: ORCL, HAIN, ACN, SCS, ATUS, NVS, GSK & more

    These are the stocks posting the largest moves before the bell.